Postmenopausal Estrogen/Progestin Interventions

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial was a large randomized controlled trial which assessed the influence of menopausal hormone therapy on cardiovascular and other outcomes.[1][2][3][4]

References
  1. Barrett-Connor E (December 1995). "Postmenopausal estrogen and heart disease". Atherosclerosis. 118 Suppl: S7–10. doi:10.1016/0021-9150(95)90068-3. PMID 8821460.
  2. Fitzpatrick LA, Good A (September 1999). "Micronized progesterone: clinical indications and comparison with current treatments". Fertil. Steril. 72 (3): 389–97. doi:10.1016/s0015-0282(99)00272-1. PMID 10519605.
  3. Stefanick ML (February 1999). "Estrogen, progestogens and cardiovascular risk". J Reprod Med. 44 (2 Suppl): 221–6. PMID 11392036.
  4. Pike MC (July 2005). "The role of mammographic density in evaluating changes in breast cancer risk". Gynecol. Endocrinol. 21 Suppl 1: 1–5. doi:10.1080/09513590400030038. PMID 16112948.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.